Skip to content
10-Q

Quarterly Report

Glucose Health, Inc. GLUC

0001477932-17-002253

← back to feed
Filed
May 15, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 15, 2017 3.42M sh
Operating Cash Flow Q1 2017 · Mar 31, 2017 −$11.53K
Operating Cash Flow Q1 2017 · Mar 31, 2016 −$48.61K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $9.01K
Cash And Equivalents Q1 2017 · Dec 31, 2016 $20.54K
Cash And Equivalents Q1 2017 · Dec 31, 2015 $2.06K
Stockholders Equity Q1 2017 · Mar 31, 2017 −$523.57K
Stockholders Equity Q1 2017 · Dec 31, 2016 −$495.45K
Current Liabilities Q1 2017 · Mar 31, 2017 $542.43K
Current Liabilities Q1 2017 · Dec 31, 2016 $528.59K
Total Liabilities Q1 2017 · Mar 31, 2017 $542.43K
Total Liabilities Q1 2017 · Dec 31, 2016 $528.59K
Current Assets Q1 2017 · Mar 31, 2017 $18.64K
Current Assets Q1 2017 · Dec 31, 2016 $32.91K
Total Assets Q1 2017 · Mar 31, 2017 $18.87K
Total Assets Q1 2017 · Dec 31, 2016 $33.15K
Eps Basic Q1 2017 · Mar 31, 2017 −$0.01
Eps Basic Q1 2017 · Mar 31, 2016 −$0.01
Sga Expense Q1 2017 · Mar 31, 2017 $12.49K
Sga Expense Q1 2017 · Mar 31, 2016 $2.92K
Net Income Q1 2017 · Mar 31, 2017 −$29.01K
Net Income Q1 2017 · Mar 31, 2016 −$29.26K
Operating Income Q1 2017 · Mar 31, 2017 −$28.31K
Operating Income Q1 2017 · Mar 31, 2016 −$12.28K
Gross Profit Q1 2017 · Mar 31, 2017 $473
Gross Profit Q1 2017 · Mar 31, 2016 $60
Cost Of Revenue Q1 2017 · Mar 31, 2017 $14.64K
Cost Of Revenue Q1 2017 · Mar 31, 2016 $60